Literature DB >> 1181076

Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro.

S C Knight, E M Lance, J Abbosh, A Munro, J O'Brien.   

Abstract

Lymphocytes from fifteen multiple sclerosis patients gave responses to phytohaemagglutinin (PHA), conconavalin A (con A) and pokeweed mitogen (PWM) which were in the normal range. However, the responses of lymphocytes to stimulation by an allogeneic lymphoid cell line (LCL) were significantly lower in HLA-7-positive than in HLA-7-negative patients (a distinction not found in control groups). Depression of con A, PHA and PWM responses were observed during intensive immunosuppression. Responses to LCL were unaltered or increased during initial azathioprine and prednisone treatment. The depression of this response following antilymphocyte globulin (ALG) treatment was delayed in the HLA-7-positive patients. One week after the end of ALG treatment, most PHA, con A and PWM responses had returned to low normal values. Reduction of azathioprine and prednisone treatment at the end of 1 year resulted in a sharp rise in PHA and con A responses in some patients. Relapses in patients were frequently associated with low responses to LCL cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1181076      PMCID: PMC1538247     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Immune status of patients with multiple sclerosis. Analysis of primary and established immune responses in 24 patients.

Authors:  L E Davis; E M Hersh; J E Curtis; R E Lynch; D K Ziegler; J W Neumann; T D Chin
Journal:  Neurology       Date:  1972-10       Impact factor: 9.910

2.  Separation of populations of human lymphocytes by freezing and thawing.

Authors:  S C Knight; J Farrant; G J Morris
Journal:  Nat New Biol       Date:  1972-09-20

Review 3.  Multiple sclerosis: an immunologic reassessment.

Authors:  P Y Paterson
Journal:  J Chronic Dis       Date:  1973-03

4.  Letter: HL-A-antigen segregation analysis in multiple sclerosis.

Authors:  J Bertrams; E Kuwert
Journal:  Lancet       Date:  1974-07-06       Impact factor: 79.321

5.  Functional heterogeneity of murine lymphoid cells. II. Acquisition of mitogen responsiveness and of theta antigen during the ontogeny of thymocytes and "T" lymphocytes.

Authors:  J D Stobo; W E Paul
Journal:  Cell Immunol       Date:  1972-08       Impact factor: 4.868

6.  Immunologic reactivity in rheumatoid arthritis. Response to mitogens.

Authors:  E M Lance; S C Knight
Journal:  Arthritis Rheum       Date:  1974 Sep-Oct

7.  Some observations on the in vitro reactivity of lymphoid subpopulations.

Authors:  B Diamond; S C Knight; E M Lance
Journal:  Cell Immunol       Date:  1974-03-30       Impact factor: 4.868

8.  Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor.

Authors:  M Knowles; D Hughes; E A Caspary; E J Field
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

9.  Lymphocyte trnsformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases.

Authors:  D Hughes; E A Caspary; E J Field
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

10.  Lymphocyte transformation in mutliple sclerosis induced by cerebrospinal fluid.

Authors:  I Fowler; C E Morris; T Whitley
Journal:  N Engl J Med       Date:  1966-11-10       Impact factor: 91.245

View more
  5 in total

1.  Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.

Authors:  E M Lance; M Kremer; J Abbosh; V E Jones; S Knight; P B Medawar
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330

Review 2.  The evidence justifying immunosuppression therapy in multiple sclerosis.

Authors:  J Mertin
Journal:  Proc R Soc Med       Date:  1977-12

3.  Spontaneous and mutagen induced sister chromatid exchange in multiple sclerosis.

Authors:  M S Newton; C M Steel; H J Evans; B Pentland
Journal:  J Med Genet       Date:  1983-10       Impact factor: 6.318

4.  T-cell subsets in multiple sclerosis: lack of correlation between helper and suppressor T cells and the clinical state.

Authors:  J B Zabriskie; L Mayer; S M Fu; C Yeadon; V Cam; C Plank
Journal:  J Clin Immunol       Date:  1985-01       Impact factor: 8.317

5.  Cell number requirements for lymphocyte stimulation in vitro: changes during the course of multiple sclerosis and the effects of immunosuppression.

Authors:  S C Knight; B Harding; S Burman; J Mertin
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.